| For weeks, I've been sharing how my Auspex stock screener has uncovered big gains in just 30 days. And the back tested results speak for themselves: - 117% from Fulgent Genetics
When we opened this research to a small group of readers, they had the chance to make 115% in under 60 days from Aveanna Healthcare. Now, I've officially launched this powerful research to the public, and the momentum is already building. Our current open positions include gains as high as 40% and 25% — and that's just the start. Here's Why You Should Act Now… In just a few days, I'm releasing a brand-new model portfolio with "best-in-class" stock picks for January. These are the stocks I believe are primed to deliver massive potential gains in the next 30-60 days. But there's one catch: this opportunity is only available for a limited time. If you want to: - Be among the first to access my January model portfolio…
- Lock in the heavily discounted charter member offer (70% off retail)…
- And test-drive my research for 90 days…
You need to act fast. This offer closes on January 1 at midnight. This is your chance to start the new year ahead of the markets, with the confidence of having a powerful strategy for finding the best stocks every month throughout 2025. Here's to your success,
Luke Lango
Senior Investment Analyst, InvestorPlace | 
No comments:
Post a Comment